retatrutide clinical trial phase retatrutide Availability & Timeline Retatrutide Dosing: Early Clinical Trial

As of March 2026, retatrutide is investigational

That answer is coming, but it is not here yet

Many patients and their families are now in search of natural therapies to treat ADHD rather than being on stimulants that have addictive properties

Additionally, because GLP-1 receptor agonists slow gastric emptying, the absorption of some oral medicines particularly those with a narrow therapeutic index (such as certain anticoagulants or antiepileptics) may be affected

Weekends for me are all about flexibilityand a little bit of takeout

Mechanisms by Which Glucagon-Like-Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors Reduce Cardiovascular Risk in Adults With Type 2 Diabetes Mellitus